Mayinglong Pharmaceutical Group Co., Ltd. Class ASSE: 600993

"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for 2025

Jul 29, 2026 · Issued by Mayinglong Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Mayinglong Pharmaceutical Group Co., Ltd. Class A

"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on the Listing and Trading of Restricted Shares from the Share ReformJul 17
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Obtaining Drug Registration Certificate by SubsidiaryJul 11
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on the Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List"Jul 10
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei JurisdictionJul 3

All Mayinglong Pharmaceutical Group Co., Ltd. Class A news releases